• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对大流行 A(H1N1) 流感的疫苗病毒的开发。

The development of vaccine viruses against pandemic A(H1N1) influenza.

机构信息

Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar EN6 3QG, UK.

出版信息

Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.

DOI:10.1016/j.vaccine.2010.12.044
PMID:21199698
Abstract

Wild type human influenza viruses do not usually grow well in embryonated hens' eggs, the substrate of choice for the production of inactivated influenza vaccine, and vaccine viruses need to be developed specifically for this purpose. In the event of a pandemic of influenza, vaccine viruses need to be created with utmost speed. At the onset of the current A(H1N1) pandemic in April 2009, a network of laboratories began a race against time to develop suitable candidate vaccine viruses. Two approaches were followed, the classical reassortment approach and the more recent reverse genetics approach. This report describes the development and the characteristics of current pandemic H1N1 candidate vaccine viruses.

摘要

野生型人流感病毒通常在鸡胚中不能很好地生长,而鸡胚是生产灭活流感疫苗的首选基质,因此需要专门开发疫苗病毒。在流感大流行的情况下,需要以最快的速度创建疫苗病毒。在 2009 年 4 月当前的 A(H1N1)大流行开始时,一个实验室网络开始了一场与时间的赛跑,以开发合适的候选疫苗病毒。采用了两种方法,经典的重配方法和最近的反向遗传学方法。本报告描述了当前大流行 H1N1 候选疫苗病毒的开发和特性。

相似文献

1
The development of vaccine viruses against pandemic A(H1N1) influenza.针对大流行 A(H1N1) 流感的疫苗病毒的开发。
Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.
2
Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.大流行性流感 A(H1N1)的教训:基于研究的疫苗产业的观点。
Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27.
3
Pandemic influenza A (H1N1) 2009 vaccine: an update.2009年甲型H1N1大流行性流感疫苗:最新情况
Indian J Med Microbiol. 2011 Jan-Mar;29(1):13-8. doi: 10.4103/0255-0857.76517.
4
Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.2009 年大流行流感 A(H1N1)疫苗接种后基线血清阳性率较高的学龄儿童的血清学反应和持久性。
Vaccine. 2011 Jan 17;29(4):617-23. doi: 10.1016/j.vaccine.2010.11.016. Epub 2010 Nov 21.
5
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.AS03(A) 佐剂疫苗对血液透析患者 2009 年甲型 H1N1 流感的免疫原性和疗效:一项非随机试验。
Am J Kidney Dis. 2011 May;57(5):716-23. doi: 10.1053/j.ajkd.2010.11.031. Epub 2011 Feb 23.
6
Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.使用人、禽和猪甲型流感病毒生成和评估三价灭活重配疫苗。
Vaccine. 2008 Jun 2;26(23):2912-8. doi: 10.1016/j.vaccine.2008.03.048. Epub 2008 Apr 11.
7
A note on the use of influenza vaccination strategies when supply is limited.关于供应有限时使用流感疫苗接种策略的说明。
Math Biosci Eng. 2011 Jan;8(1):171-82. doi: 10.3934/mbe.2011.8.171.
8
Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.开发欧亚H7N7/PR8高生长重组病毒作为灭活大流行性流感疫苗进行临床评估。
Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.
9
Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).2009 - 2010年大流行性流感疫苗:六点经验教训及未来方向(快板而非慢板)
Vaccine. 2011 Jan 17;29(4):613-4. doi: 10.1016/j.vaccine.2010.11.086.
10
Influenza vaccines: the good, the bad, and the eggs.流感疫苗:优劣与鸡蛋。
Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X.

引用本文的文献

1
Respiratory infection with Enterovirus D68 induces severe acute lung inflammation in the pediatric ferret model.肠道病毒D68引起的呼吸道感染在幼雪貂模型中诱发严重的急性肺部炎症。
iScience. 2025 Jul 5;28(8):113071. doi: 10.1016/j.isci.2025.113071. eCollection 2025 Aug 15.
2
A High-Yield Recombinant Inactivated Whole-Virion Nasal Influenza A(H1N1)pdm09 Virus Vaccine with an Attenuated PB2 Gene.一种具有减毒PB2基因的高产重组灭活全病毒甲型H1N1pdm09流感病毒疫苗。
Int J Mol Sci. 2025 Jun 7;26(12):5489. doi: 10.3390/ijms26125489.
3
Reply to Ebright et al., "Implementing governmental oversight of enhanced potential pandemic pathogen research".
回复埃布赖特等人的《实施对增强型潜在大流行病原体研究的政府监管》。
J Virol. 2024 Apr 16;98(4):e0025624. doi: 10.1128/jvi.00256-24. Epub 2024 Mar 13.
4
MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production.MAIVeSS:用于季节性流感疫苗生产的抗原匹配、高产量病毒的简化选择。
Nat Commun. 2024 Feb 6;15(1):1128. doi: 10.1038/s41467-024-45145-x.
5
Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs.在鸡胚中开发增强型高产流感疫苗主干。
Vaccines (Basel). 2023 Aug 15;11(8):1364. doi: 10.3390/vaccines11081364.
6
Swine-to-Ferret Transmission of Antigenically Drifted Contemporary Swine H3N2 Influenza A Virus Is an Indicator of Zoonotic Risk to Humans.抗原漂移的当代猪源 H3N2 流感 A 病毒对雪貂的传播是对人类具有人畜共患病风险的指标。
Viruses. 2023 Jan 24;15(2):331. doi: 10.3390/v15020331.
7
Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields.鉴定具有高血凝素产量的 H5 流感疫苗病毒的特性。
PLoS One. 2023 Jan 20;18(1):e0280811. doi: 10.1371/journal.pone.0280811. eCollection 2023.
8
Interspecies Transmission from Pigs to Ferrets of Antigenically Distinct Swine H1 Influenza A Viruses with Reduced Reactivity to Candidate Vaccine Virus Antisera as Measures of Relative Zoonotic Risk.猪对抗原不同的猪源 H1 流感病毒向雪貂的种间传播,这些病毒对候选疫苗病毒抗血清的反应性降低,作为相对人畜共患病风险的衡量标准。
Viruses. 2022 Oct 29;14(11):2398. doi: 10.3390/v14112398.
9
Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.使用具有末端唾液酸敲除细胞的新型生物系统揭示甲型流感病毒无受体嗜性。
J Virol. 2022 Aug 10;96(15):e0041622. doi: 10.1128/jvi.00416-22. Epub 2022 Jul 18.
10
Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding.血凝素替换 N125D、D127E、D222G 和 R223Q 通过增强 α-2,6 受体结合提高了 A/H1N1pdm09 减毒流感疫苗病毒的复制适应性和疫苗效力。
PLoS Pathog. 2022 May 27;18(5):e1010585. doi: 10.1371/journal.ppat.1010585. eCollection 2022 May.